Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628908-26-000002
Filing Date
2026-01-05
Accepted
2026-01-05 16:10:53
Documents
5
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1767647449.html 3  
1 FORM 3 wk-form3_1767647449.xml 3 2301
2 EX-24 a3evh-poatemplatervsd112.htm EX-24 13207
3 a3evh-poatemplatervsd112001.jpg GRAPHIC 288871
4 a3evh-poatemplatervsd112002.jpg GRAPHIC 263512
5 a3evh-poatemplatervsd112003.jpg GRAPHIC 40393
  Complete submission text file 0001628908-26-000002.txt   833661
Mailing Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209
Business Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209 571-389-6000
Evolent Health, Inc. (Issuer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8741 Services-Management Services
(CF Office: 07 Trade & Services)

Mailing Address C/O EVOLV TECHNOLOGIES, INC. 500 TOTTEN POND ROAD, 4TH FLOOR WALTHAM MA 02451
Business Address
Ramos Mario (Reporting) CIK: 0001891060 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37415 | Film No.: 26506095